Kayıkçıoglu, E., and E. Findos. “The Prognostic Immune Nutritional Index Is a Predictive Biomarker in Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone or Enzalutamide: Prognostic Immune Nutritional Index and Prostate Adenocancer”. The Injector, vol. 1, no. 3, Nov. 2022, pp. 106-14, doi:10.5281/zenodo.7331456.